Renal tubular reabsorption and secretion of urate have been separately assessed in patients with lead nephropathy by observation o f the effect on renal disposition of urate of the drug pyrazinamide, which blocks active tubular secretion of urate. Tubular reabsorption of urate was found to be greater than expected for the degree of renal failure as reflected by the inulin clearance, whereas active tubular secretion of urate was within the range predicted from the plasma urate concentration. As the hyperuricaemia of lead nephropathy has been shown to be renal in origin, these results suggest that it is mediated by excessive tubular reabsorption of urate. Though defective tubular secretion of urate has not been demonstrated, more extensive studies over a wide range of plasma urate concentrations would be needed to exclude an additional associated abnormality of the secretory process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.